United StatesTechnology

Bio-Techne (NASDAQ:TECH) reported fourth-quarter FY2026 net sales of $321.2 million, up 1% year-over-year on a reported basis and 3% organically, while GAAP EPS improved to $0.35.

Valens Semiconductor (NYSE:VLN) reported second-quarter 2026 revenue of $18.1 million, up about 6% year-over-year and above its $17.2–$17.6 million guidance.

Allot (NASDAQ:ALLT, TASE:ALLT) reported second-quarter 2026 revenue of $27.7 million, up 15% year-over-year, as SECaaS revenue increased 47% to $9.4 million.

Boyd Group Services (NYSE:BGSI) reported second-quarter 2026 sales of $1.0137 billion, up 29.9% year over year, while gross margin increased to 47.4%.

National Vision Holdings (NASDAQ:EYE) reported second-quarter 2026 financial results with net revenue of $498.8 million, up 2.5%, and comparable store sales growth of 3.4% for the quarter ended July 4, 2026.

CoreWeave's revenue rose 112% year on year to $2.58 billion, yet adjusted operating income fell to $128 million from $200 million.

CoreWeave (NASDAQ:CRWV) reported second-quarter 2026 revenue of $2.58 billion, more than doubling year over year, while revenue backlog reached approximately $104 billion.

Super Micro Computer (NASDAQ:SMCI) reported fiscal fourth-quarter 2026 net sales of $11.1 billion, up about 91% from $5.8 billion a year earlier.

Riot Platforms (NASDAQ:RIOT) signed a 20-year, 191 MW AI data-center lease expected by the company to generate approximately $9.1 billion in contract revenue.

DarioHealth (NASDAQ:DRIO) reported second-quarter 2026 revenue of $5.2 million, down about 4% year over year, while gross margin improved to 61.7%.

Alcon (NYSE:ALC) reported second-quarter 2026 net sales of $2.78 billion, up 8% year over year, while core diluted EPS reached $0.84.

908 Devices (NASDAQ:MASS) reported second-quarter 2026 revenue of $16.1 million, up 23% year over year, as VipIR and NIRLab sales supported growth.